Dermatologicals Market 2027 By Dermatological Disease, Drug Type, Route of Administration | The Insight Partners

Dermatologicals Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dermatological Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia); Drug Type (Prescription-Based Drugs, Over-the-Counter Drugs); Route of Administration (Topical, Oral, Parenteral Administration)

Report Code: TIPRE00015275 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Dermatology is a medicine field engaged in the diagnosis, prevention, and treatment of various diseases related to nails, skin, and hair, such as pigmentation, acne, wrinkles, and psoriasis. The products are used to treat skin conditions and are also employed to prevent certain skin disorders. Furthermore, dermatological is also used for routine skin care to maintain one's skin. However, some of the dermatological are systemic preparations used in patients who does not responsive to topical medicines. Moreover, all these preparations are used to treat various skin conditions, such as dermatitis, acne, and psoriasis.

MARKET DYNAMICS

The Dermatologicals market is expected to grow significantly in the coming years, due to rising incidence of skin diseases globally. Moreover, technological advancements in field of dermatology supported by FDA approvals anticipated to influence the end-user of Dermatologicals .

MARKET SCOPE

The "Dermatologicals Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Dermatologicals market with detailed market segmentation by dermatological disease, drug type and route of administration. The Dermatologicals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in dermatologicals market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Dermatologicals market is segmented on the basis of dermatological disease, drug type and route of administration. Based on dermatological disease , the market is segmented into Acne, Dermatitis, Psoriasis , Skin Cancer , Rosacea , Alopecia. On the basis of Drug Type , the market is categorized as Prescription-Based Drugs , Over-the-Counter Drugs. On the basis of Route of Administration, the market is categorized as Topical, Oral, Parenteral Administration.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Dermatologicals market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Dermatologicals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Dermatologicals market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Dermatologicals market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Dermatologicals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Dermatologicals market are anticipated to have lucrative growth opportunities in the future with the rising demand for Dermatologicals in the global market. Below mentioned is the list of few companies engaged in the Dermatologicals market.

The report also includes the profiles of key players in Dermatologicals market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Bayer AG,
  •   Johnson & Johnson,
  •   Pfizer Inc., Novartis AG,
  •   GlaxoSmithKline plc,
  •   AstraZeneca,
  •   Galderma S.A.,
  •   Amgen Inc.,
  •   AbbVie Inc.,
  •   Merck KGaA
  •   Novartis AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dermatologicals Market - By Dermatological Disease
1.3.2 Dermatologicals Market - By Drug Type
1.3.3 Dermatologicals Market - By Route of Administration
1.3.4 Dermatologicals Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DERMATOLOGICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DERMATOLOGICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DERMATOLOGICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. DERMATOLOGICALS - GLOBAL MARKET OVERVIEW
6.2. DERMATOLOGICALS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DERMATOLOGICALS MARKET - REVENUE AND FORECASTS TO 2027 - DERMATOLOGICAL DISEASE
7.1. OVERVIEW
7.2. DERMATOLOGICAL DISEASE MARKET FORECASTS AND ANALYSIS
7.3. ACNE
7.3.1. Overview
7.3.2. Acne Market Forecast and Analysis
7.4. DERMATITIS
7.4.1. Overview
7.4.2. Dermatitis Market Forecast and Analysis
7.5. PSORIASIS
7.5.1. Overview
7.5.2. Psoriasis Market Forecast and Analysis
7.6. SKIN CANCER
7.6.1. Overview
7.6.2. Skin Cancer Market Forecast and Analysis
7.7. ROSACEA
7.7.1. Overview
7.7.2. Rosacea Market Forecast and Analysis
7.8. ALOPECIA
7.8.1. Overview
7.8.2. Alopecia Market Forecast and Analysis
8. DERMATOLOGICALS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. PRESCRIPTION-BASED DRUGS
8.3.1. Overview
8.3.2. Prescription-Based Drugs Market Forecast and Analysis
8.4. OVER-THE-COUNTER DRUGS
8.4.1. Overview
8.4.2. Over-the-Counter Drugs Market Forecast and Analysis
9. DERMATOLOGICALS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. TOPICAL
9.3.1. Overview
9.3.2. Topical Market Forecast and Analysis
9.4. ORAL
9.4.1. Overview
9.4.2. Oral Market Forecast and Analysis
9.5. PARENTERAL ADMINISTRATION
9.5.1. Overview
9.5.2. Parenteral Administration Market Forecast and Analysis
10. DERMATOLOGICALS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Dermatologicals Market Overview
10.1.2 North America Dermatologicals Market Forecasts and Analysis
10.1.3 North America Dermatologicals Market Forecasts and Analysis - By Dermatological Disease
10.1.4 North America Dermatologicals Market Forecasts and Analysis - By Drug Type
10.1.5 North America Dermatologicals Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Dermatologicals Market Forecasts and Analysis - By Countries
10.1.6.1 United States Dermatologicals Market
10.1.6.1.1 United States Dermatologicals Market by Dermatological Disease
10.1.6.1.2 United States Dermatologicals Market by Drug Type
10.1.6.1.3 United States Dermatologicals Market by Route of Administration
10.1.6.2 Canada Dermatologicals Market
10.1.6.2.1 Canada Dermatologicals Market by Dermatological Disease
10.1.6.2.2 Canada Dermatologicals Market by Drug Type
10.1.6.2.3 Canada Dermatologicals Market by Route of Administration
10.1.6.3 Mexico Dermatologicals Market
10.1.6.3.1 Mexico Dermatologicals Market by Dermatological Disease
10.1.6.3.2 Mexico Dermatologicals Market by Drug Type
10.1.6.3.3 Mexico Dermatologicals Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Dermatologicals Market Overview
10.2.2 Europe Dermatologicals Market Forecasts and Analysis
10.2.3 Europe Dermatologicals Market Forecasts and Analysis - By Dermatological Disease
10.2.4 Europe Dermatologicals Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Dermatologicals Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Dermatologicals Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Dermatologicals Market
10.2.6.1.1 Germany Dermatologicals Market by Dermatological Disease
10.2.6.1.2 Germany Dermatologicals Market by Drug Type
10.2.6.1.3 Germany Dermatologicals Market by Route of Administration
10.2.6.2 France Dermatologicals Market
10.2.6.2.1 France Dermatologicals Market by Dermatological Disease
10.2.6.2.2 France Dermatologicals Market by Drug Type
10.2.6.2.3 France Dermatologicals Market by Route of Administration
10.2.6.3 Italy Dermatologicals Market
10.2.6.3.1 Italy Dermatologicals Market by Dermatological Disease
10.2.6.3.2 Italy Dermatologicals Market by Drug Type
10.2.6.3.3 Italy Dermatologicals Market by Route of Administration
10.2.6.4 Spain Dermatologicals Market
10.2.6.4.1 Spain Dermatologicals Market by Dermatological Disease
10.2.6.4.2 Spain Dermatologicals Market by Drug Type
10.2.6.4.3 Spain Dermatologicals Market by Route of Administration
10.2.6.5 United Kingdom Dermatologicals Market
10.2.6.5.1 United Kingdom Dermatologicals Market by Dermatological Disease
10.2.6.5.2 United Kingdom Dermatologicals Market by Drug Type
10.2.6.5.3 United Kingdom Dermatologicals Market by Route of Administration
10.2.6.6 Rest of Europe Dermatologicals Market
10.2.6.6.1 Rest of Europe Dermatologicals Market by Dermatological Disease
10.2.6.6.2 Rest of Europe Dermatologicals Market by Drug Type
10.2.6.6.3 Rest of Europe Dermatologicals Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Dermatologicals Market Overview
10.3.2 Asia-Pacific Dermatologicals Market Forecasts and Analysis
10.3.3 Asia-Pacific Dermatologicals Market Forecasts and Analysis - By Dermatological Disease
10.3.4 Asia-Pacific Dermatologicals Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Dermatologicals Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Dermatologicals Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Dermatologicals Market
10.3.6.1.1 Australia Dermatologicals Market by Dermatological Disease
10.3.6.1.2 Australia Dermatologicals Market by Drug Type
10.3.6.1.3 Australia Dermatologicals Market by Route of Administration
10.3.6.2 China Dermatologicals Market
10.3.6.2.1 China Dermatologicals Market by Dermatological Disease
10.3.6.2.2 China Dermatologicals Market by Drug Type
10.3.6.2.3 China Dermatologicals Market by Route of Administration
10.3.6.3 India Dermatologicals Market
10.3.6.3.1 India Dermatologicals Market by Dermatological Disease
10.3.6.3.2 India Dermatologicals Market by Drug Type
10.3.6.3.3 India Dermatologicals Market by Route of Administration
10.3.6.4 Japan Dermatologicals Market
10.3.6.4.1 Japan Dermatologicals Market by Dermatological Disease
10.3.6.4.2 Japan Dermatologicals Market by Drug Type
10.3.6.4.3 Japan Dermatologicals Market by Route of Administration
10.3.6.5 South Korea Dermatologicals Market
10.3.6.5.1 South Korea Dermatologicals Market by Dermatological Disease
10.3.6.5.2 South Korea Dermatologicals Market by Drug Type
10.3.6.5.3 South Korea Dermatologicals Market by Route of Administration
10.3.6.6 Rest of Asia-Pacific Dermatologicals Market
10.3.6.6.1 Rest of Asia-Pacific Dermatologicals Market by Dermatological Disease
10.3.6.6.2 Rest of Asia-Pacific Dermatologicals Market by Drug Type
10.3.6.6.3 Rest of Asia-Pacific Dermatologicals Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Dermatologicals Market Overview
10.4.2 Middle East and Africa Dermatologicals Market Forecasts and Analysis
10.4.3 Middle East and Africa Dermatologicals Market Forecasts and Analysis - By Dermatological Disease
10.4.4 Middle East and Africa Dermatologicals Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Dermatologicals Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Dermatologicals Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Dermatologicals Market
10.4.6.1.1 South Africa Dermatologicals Market by Dermatological Disease
10.4.6.1.2 South Africa Dermatologicals Market by Drug Type
10.4.6.1.3 South Africa Dermatologicals Market by Route of Administration
10.4.6.2 Saudi Arabia Dermatologicals Market
10.4.6.2.1 Saudi Arabia Dermatologicals Market by Dermatological Disease
10.4.6.2.2 Saudi Arabia Dermatologicals Market by Drug Type
10.4.6.2.3 Saudi Arabia Dermatologicals Market by Route of Administration
10.4.6.3 U.A.E Dermatologicals Market
10.4.6.3.1 U.A.E Dermatologicals Market by Dermatological Disease
10.4.6.3.2 U.A.E Dermatologicals Market by Drug Type
10.4.6.3.3 U.A.E Dermatologicals Market by Route of Administration
10.4.6.4 Rest of Middle East and Africa Dermatologicals Market
10.4.6.4.1 Rest of Middle East and Africa Dermatologicals Market by Dermatological Disease
10.4.6.4.2 Rest of Middle East and Africa Dermatologicals Market by Drug Type
10.4.6.4.3 Rest of Middle East and Africa Dermatologicals Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Dermatologicals Market Overview
10.5.2 South and Central America Dermatologicals Market Forecasts and Analysis
10.5.3 South and Central America Dermatologicals Market Forecasts and Analysis - By Dermatological Disease
10.5.4 South and Central America Dermatologicals Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Dermatologicals Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Dermatologicals Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Dermatologicals Market
10.5.6.1.1 Brazil Dermatologicals Market by Dermatological Disease
10.5.6.1.2 Brazil Dermatologicals Market by Drug Type
10.5.6.1.3 Brazil Dermatologicals Market by Route of Administration
10.5.6.2 Argentina Dermatologicals Market
10.5.6.2.1 Argentina Dermatologicals Market by Dermatological Disease
10.5.6.2.2 Argentina Dermatologicals Market by Drug Type
10.5.6.2.3 Argentina Dermatologicals Market by Route of Administration
10.5.6.3 Rest of South and Central America Dermatologicals Market
10.5.6.3.1 Rest of South and Central America Dermatologicals Market by Dermatological Disease
10.5.6.3.2 Rest of South and Central America Dermatologicals Market by Drug Type
10.5.6.3.3 Rest of South and Central America Dermatologicals Market by Route of Administration
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DERMATOLOGICALS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DERMATOLOGICALS MARKET, KEY COMPANY PROFILES
13.1. BAYER AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. JOHNSON AND JOHNSON
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC., NOVARTIS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE PLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ASTRAZENECA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GALDERMA S.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. AMGEN INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ABBVIE INC.,
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MERCK KGAA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NOVARTIS AG
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Johnson & Johnson,
3. Pfizer Inc., Novartis AG,
4. GlaxoSmithKline plc,
5. AstraZeneca,
6. Galderma S.A.,
7. Amgen Inc.,
8. AbbVie Inc.,
9. Merck KGaA
10. Novartis AG
TIPRE00015275
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking